Answers are grounded in this paper and cite their sources.
REALISE Task 2.1 conducts stakeholder mapping and community management to provide the foundation for establishing and maintaining the REALISE stakeholder community and their involvement within the project. It supports the identification of relevant key players as well as the development of an appropriate engagement strategy that is implemented throughout the entire duration of the project. Depending on their role, experience, knowledge, and other resources, stakeholders may be engaged through co-creation, communication, dissemination, and exploitation activities. In particular, the stakeholder mapping supports: WP3 in identifying knowledge gaps and prioritising research needs; WP4 in involving stakeholders in the design of studies and research questions, and ensuring continuous exchange throughout the empirical work; WP5 by engaging stakeholder contributions to understanding contextual and institutional conditions for reform and to developing and validating the “Readiness and Implementation Pathways Framework”; and, finally, WP6 in involving stakeholders in the joint synthesis of findings and the development of practice-oriented recommendations for action. This Deliverable report (D2.1) thus identifies the relevant key actors, explains their relationship to the project and its expected outcomes. In this way, it helps ensure that REALISE not only establishes a robust evidence base for research assessment reform but also creates connections and pathways to stakeholders required for the project’s results to be understood, utilised, and taken forward within the European research and innovation ecosystem.
No takes yet. Share an insight, caveat, or question.
Batljan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: